Skip to main content

Benjamin Solomon Freedman

NIH Rank #6837
  • Program Leader
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10307161Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2025

Linked Award Amount
$2M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#6,837
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Benjamin Solomon Freedman. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Benjamin Solomon Freedman as a PI. Multi-PI records show the full award amount for context.

  • 2R42DK136452-02A1R42
    Targeting Myosin to Treat Polycystic Kidney Disease
    $839.3K
    award amount
  • 5U2CTR004867-03U2C
    Translational center for kidney microphysiological systems to improve drug safety and efficacy
    $725.8K
    award amount
  • 5U01AI176460-03U01
    Utility of Human Organoids for Safety and Efficiency Evaluations of Genome Editing Therapeutics
    $341.8K
    award amount
  • 5U2CDK140919-02U2C
    Northwest Comprehensive Research Training in Kidney, Urologic, and Hematologic Sciences (NCOR-KUH)
    $52.4K
    award amount
  • 1U54DK144864-01U54
    Polycystic Kidney Disease In Vitro Center (PKD-InVent)
    $25K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Benjamin Solomon Freedman as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Plurexa Llc
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4206
  6. 2024
    Entered Top 25% Nationally
    Ranked #4206
  7. 2025
    Multi-Institutional Research
    Awards at 3 institutions
  8. 2025
    Program/Center Grant Leader
  9. 2026
    $5M Cumulative Funding